These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7717384)

  • 1. Hairy cell leukemia: treatment results and association with secondary malignancy.
    Kwong YL; Liang R; Chiu E; Chan DW; Chan TK
    Am J Hematol; 1995 Apr; 48(4):291. PubMed ID: 7717384
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature.
    Al-Fiar F; Meharchand J; Curtis J; Lipton JH
    Leuk Res; 1999 Aug; 23(8):719-21. PubMed ID: 10456669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the development of T-cell leukaemia in the patient successfully treated by interferon-alpha for typical hairy cell leukaemia (HCL).
    Demeter J; Paloczi K
    Leukemia; 1992 Nov; 6(11):1235-6. PubMed ID: 1290544
    [No Abstract]   [Full Text] [Related]  

  • 4. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S
    Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
    Seshadri P
    Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
    [No Abstract]   [Full Text] [Related]  

  • 8. Do we know the treatment of choice for hairy cell leukemia?
    Golomb HM
    Ann Oncol; 1994 Oct; 5(8):676-7. PubMed ID: 7826898
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Setoodeh R; Zhang L
    Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.
    Lenz G; Golf A; Rüdiger T; Hiddemann W; Haferlach T
    Blood; 2003 Nov; 102(9):3457-8. PubMed ID: 14568909
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukemia in father and son.
    Cetiner M; Adigüzel C; Argon D; Ratip S; Eksioglu-Demiralp E; Tecimer T; Bayik M
    Med Oncol; 2003; 20(4):375-8. PubMed ID: 14716034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
    Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second cancer risk in hairy cell leukemia: analysis of 350 patients.
    Kurzrock R; Strom SS; Estey E; O'Brien S; Keating MJ; Jiang H; Adams T; Talpaz M
    J Clin Oncol; 1997 May; 15(5):1803-10. PubMed ID: 9164188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
    Dasanu CA; Alexandrescu DT
    Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment for untreated patients with hairy cell leukemia?
    Troussard X; Flandrin G
    J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.